BioTech

STMicroelectronics’ biosensing technology enables next-generation wearables for individual healthcare and fitness 

STMicroelectronics, has introduced a new bio-sensing chip for the next generations of healthcare wearables like smart watches, sports bands, connected rings or smart glasses. The ST1VAFE3BX chip combines a high-accuracy biopotential input with ST’s proven i...

CEPI and Accumulus Synergy team up to enhance information equity and accelerate access to vaccines 

Accumulus Synergy’s innovative cloud-based data-sharing platform could accelerate access to vaccines and other health technologies by enabling multi-country regulatory submissions and expediting regulatory review and approval, potentially helping to end f...

Roche to acquire Poseida Therapeutics, including its related platform tech

Roche has announced that it has entered into a definitive merger agreement to acquire Poseida Therapeutics, a public clinical-stage biopharmaceutical company pioneering donor-derived CAR-T cell therapies. Based in San Diego, California, Poseida’s R&D p...

Roche launches the first test to use its breakthrough TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses 

Roche has announced the launch of the cobas Respiratory flex test, the first to use Roche’s novel and proprietary TAGS (Temperature-Activated Generation of Signal) technology.   TAGS technology, developed by Roche scientists, uses multiplex p...

Johnson & Johnson to invest more than US$2 billion in new, advanced technology manufacturing facility in North Carolina to support robust portfolio growth 

Johnson & Johnson has announced an investment of more than US$2 billion to build a state-of-the-art biologics manufacturing facility in Wilson, North Carolina. The new facility will expand production of the Company’s portfolio and pipeline of innovative b...

Genetic Leap and Lilly enter collaboration to accelerate genetic medicine development with AI 

Genetic Leap, an AI-native techbio company innovating at the cutting edge of Artificial Intelligence and RNA genetic medicine, has announced a research collaboration with Eli Lilly and Company to develop genetic medicine therapeutics.  The...

Robots help put brakes on inflammatory diseases

Automated diagnostic techniques, such as liquid-handling robots, could significantly enhance the lives of those with inflammatory diseases. A WEHI study has introduced new, reproducible methods for detecting necroptosis, promising improved diagnosis and...

The University of Manchester set to put the north-west on the BioTech map with coalition launch 

The Industrial Biotechnology Innovation Catalyst (IBIC), launched by The University of Manchester has established the north-west of England as a global leader in biotechnology innovation, boosting job creation, collaboration, investment and upskilling in the...

New heart disease calculator could save lives by identifying high-risk patients missed by current tools 

Collaborative research, led from the University of Oxford and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual’s 10-year risk of cardiovascular diseases, like heart disease and stroke,...

Medtronic Diabetes announces world’s first approval for MiniMe 780G System with Simplera Sync disposable, all-in-one sensor 

Medtronic, a global leader in healthcare technology, received CE (Conformité Européenne) Mark approval for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM) requiring no fingersticks or overtape. Simplera S...

Ocutrx unveils OcuLenz AR/XR headset, aiding vision for patients with advanced macular degeneration 

Ocutrx Technologies, a leader in Augmented Reality (AR) and 3D technology for medical and surgical applications is pulling back the curtain on its latest innovation: OcuLenz, its groundbreaking Augmented Reality (AR) / Extended Reality (XR) headset. OcuLenz...

The continuous glucose monitoring device designed for non-invasive diabetes management 

Phillips-Medisize, a Molex company and a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, invitro diagnostic and MedTech devices, has teamed with GlucoModicum, an innovative MedTech company based in Finland, to design and...